CD38 Antibody – 174Yb

Catalog: 717403 
Clone: E7Z8C
Isotype: Rabbit IgG
Reactivity: Human*
Application: MIBI-FFPE
Storage: Supplied in antibody stabilizer with 0.05% sodium azide. Store at 4°C

CD38-IHC-staining-FFPE-human-colon
IHC: CD38 staining of FFPE human colon
CD38-Ionpath-MIBI-staining-FFPE-human-colon
MIBI: CD38 staining (cyan) of FFPE human colon, counterstained with dsDNA (magenta)
CD38-IHC-staining-FFPE-human-appendix
IHC: CD38 staining of FFPE human appendix
CD38-Ionpath-MIBI-staining-FFPE-human-appendix
MIBI: CD38 staining (cyan) of FFPE human appendix, counterstained with dsDNA (magenta)
Background: CD38 is a glycoprotein found on the surface of many white blood cells, including CD4+, CD8+, B lymphocytes and natural killer cells. CD38 expression is useful in identifying plasma cells and myelomas, and as a marker for activated B and T cells. CD38 expression also has prognostic implication in chronic lymphocytic leukemia.

Validation: Each lot of conjugated antibody is quality control tested by staining tissue following the MIBI Staining Protocol optimized for the applicable tissue format with subsequent MIBIscope analysis using the appropriate positive and negative tissue field of views. These results are pathologist verified.

Recommended Usage: Human FFPE: 1:100 dilution.
For optimal results, the antibody should be titrated for each desired application.

MIBI technology: Learn more about MIBI Technology, a multiplex IHC technology with unmatched sensitivity and true subcellular resolution.

References
Shaji Kumar et al. Immunophenotyping in multiple myeloma and related plasma cell disorders. Best Pract Res Clin Haematol. 2010 Sep; 23(3): 433-451.

Chuan He et al. Prognostic significance of CD38 for chronic lymphocytic leukemia: a meta-analysis. Int J Clin Exp Med 2017; 10(3): 4305-4312.

* Conjugate tested on human tissue.

Contact Us

<p style="text-align: center; margin-top: 2em;">Let us know how we can help you.</p>


    Immuno-oncology/CancerNeuroscienceInfectious DiseaseImmunologyStem CellOther

    255

    Please contact me. I understand that I can choose to unsubscribe at any time by e-mailing marketing@ionpath.com.

    X
    Contact Us

    We are using cookies on our website

    Please confirm, if you accept our tracking cookies. You can also decline the tracking and continue to visit our website without any data sent to third-party services.